Immatics (IMTX) Stock Highlights

9.88 | +3.46%

2024-10-21 02:42:11

Immatics NV is engaged in the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The companys pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers.

Statistics

Range Today

9.56 9.95

Volume Today 444.7K

Range 1 Year

7.15 13.77

Volume 1 Year 125.51M

Range 3 Year

5.75 14.9

Volume 3 Year 254.36M

Range 10 Year

0.005 18.42

Volume 10 Year 366.61M

Highlights

Market Capitalization 1.18B (small)

Floating Shares 57.36M

Current Price 9.88

Price To Earnings -10.66

Price To Revenue 12.39

Price To Book 2.63

Earnings Per Share -0.9

Payout Ratio 0%

Performance

Latest +3.46%

1 Month -18.95%

3 Months -19.81%

6 Months -3.8%

1 Year -0.9%

3 Years -27.08%

5 Years -2.76%

10 Years +197500%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.